BRD4 promotes tumor growth and epithelial-mesenchymal transition in hepatocellular carcinoma

International Journal of Immunopathology and Pharmacology

Volumn 28, Issue 1, 2015, Pages 36-44

  Zhang, Pengfei ^a   Dong, Zhaoru ^a   Cai, Jiabin ^a   Zhang, Chi ^a   Shen, Zaozhuo ^a   Ke, Aiwu ^a   Gao, Dongmei ^a   Fan, Jia ^a,b   Shi, Guoming ^a  

^a FUDAN UNIVERSITY   (China)

^b FUDAN UNIVERSITY SHANGHAI CANCER CENTER   (China)

Author keywords

Bromodomain and extraterminal domain proteins; Epigenetics; Epithelial mesenchymal transition; Hepatocellular carcinoma; Prognosis

Indexed keywords

BROMODOMAIN CONTAINING PROTEIN 4; NERVE CELL ADHESION MOLECULE; PROTEIN; SHORT HAIRPIN RNA; UNCLASSIFIED DRUG; UVOMORULIN; VIMENTIN; BRD4 PROTEIN, HUMAN; NUCLEAR PROTEIN; SMALL INTERFERING RNA; TRANSCRIPTION FACTOR;

ADULT; ARTICLE; CANCER PROGNOSIS; CANCER SURVIVAL; CANCER TISSUE; CELL GROWTH; CELL INVASION; CELL PROLIFERATION; CLINICAL ASSESSMENT; DISEASE ASSOCIATION; EPITHELIAL MESENCHYMAL TRANSITION; FEMALE; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; IN VITRO STUDY; IN VIVO STUDY; LENTIVIRINAE; LIVER CELL CARCINOMA; MAJOR CLINICAL STUDY; MALE; PHENOTYPIC VARIATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR GROWTH; TUMOR INVASION; GENE EXPRESSION REGULATION; GENETICS; HEP-G2 CELL LINE; LIVER TUMOR; MIDDLE AGED; PATHOLOGY; TRANSCRIPTION INITIATION; TUMOR CELL LINE; TUMOR RECURRENCE; UPREGULATION;

CARCINOMA, HEPATOCELLULAR; CELL LINE, TUMOR; CELL PROLIFERATION; EPITHELIAL-MESENCHYMAL TRANSITION; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; HEP G2 CELLS; HUMANS; LIVER NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; NUCLEAR PROTEINS; RNA, SMALL INTERFERING; TRANSCRIPTION FACTORS; TRANSCRIPTIONAL ACTIVATION; UP-REGULATION;

EID: 84959268216     PISSN: 03946320     EISSN: None     Source Type: Journal    
DOI: 10.1177/0394632015572070     Document Type: Article

References (27)

1. Llovet JM, Burroughs A and Bruix J (2003) Hepatocellular carcinoma. Lancet 362: 1907-1917.
2. Carr BI (2004) Hepatocellular carcinoma: current management and future trends. Gastroenterology 127: S218-224.
3. Zhu AX (2006) Systemic therapy of advanced hepatocellular carcinoma: how hopeful should we be? Oncologist 11: 790-800.
4. Irizarry RA, Hobbs B, Collin F, et al. (2003) Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistics 4: 249-264.
5. Wang R, Li Q, Helfer CM, et al. (2012) Bromodomain protein Brd4 associated with acetylated chromatin is important for maintenance of higher-order chromatin structure. Journal of Biological Chemistry 287: 10738-10752.
6. Jang MK, Mochizuki K, Zhou M, et al. (2005) The bromodomain protein Brd4 is a positive regulatory component of P-TEFb and stimulates RNA polymerase II-dependent transcription. Molecular Cell 19: 523-534.
7. Schroder S, Cho S, Zeng L, et al. (2012) Two-pronged binding with bromodomain-containing protein 4 liberates positive transcription elongation factor b from inactive ribonucleoprotein complexes. Journal of Biological Chemistry 287: 1090-1099.
8. Chiang CM (2009) Brd4 engagement from chromatin targeting to transcriptional regulation: selective contact with acetylated histone H3 and H4. F1000 Biology Reports 1: 98.
9. Yang Z, He N and Zhou Q (2008) Brd4 recruits P-TEFb to chromosomes at late mitosis to promote G1 gene expression and cell cycle progression. Molecular and Cellular Biology 28: 967-976.
10. Zhang G, Liu R, Zhong Y, et al. (2012) Down-regulation of NF-kappaB transcriptional activity in HIV-associated kidney disease by BRD4 inhibition. Journal of Biological Chemistry 287: 28840-28851.
11. Zou Z, Huang B, Wu X, et al. (2014) Brd4 maintains constitutively active NF-kappaB in cancer cells by binding to acetylated RelA. Oncogene 33: 2395-2404.
12. Segura MF, Fontanals-Cirera B, Gaziel-Sovran A, et al. (2013) BRD4 sustains melanoma proliferation and represents a new target for epigenetic therapy. Cancer Research 73: 6264-6276.
13. Lockwood WW, Zejnullahu K, Bradner JE, et al. (2012) Sensitivity of human lung adenocarcinoma cell lines to targeted inhibition of BET epigenetic signaling proteins. Proceedings of the National Academy of Sciences of the Unites States of America 109: 19408-19413.
14. Delmore JE, Issa GC, Lemieux ME, et al. (2011) BET bromodomain inhibition as a therapeutic strategy to target c-Myc. Cell 146: 904-917.
15. Dawson MA, Prinjha RK, Dittmann A, et al. (2011) Inhibition of BET recruitment to chromatin as an effective treatment for MLL-fusion leukaemia. Nature 478: 529-533.
16. Zuber J, Shi J, Wang E, et al. (2011) RNAi screen identifies Brd4 as a therapeutic target in acute myeloid leukaemia. Nature 478: 524-528.
17. Huang XY, Ke AW, Shi GM, et al. (2013) alphaB-crystallin complexes with 14-3-3zeta to induce epithelial-mesenchymal transition and resistance to sorafenib in hepatocellular carcinoma. Hepatology 57: 2235-2247.
18. Ke AW, Shi GM, Zhou J, et al. (2009) Role of over-expression of CD151 and/or c-Met in predicting prognosis of hepatocellular carcinoma. Hepatology 49: 491-503.
19. Zhang P, Zhang P, Zhou M, et al. (2013) Exon 4 deletion variant of epidermal growth factor receptor enhances invasiveness and cisplatin resistance in epithelial ovarian cancer. Carcinogenesis 34: 2639-2646.
20. Shi J, Wang Y, Zeng L, et al. (2014) Disrupting the interaction of BRD4 with diacetylated Twist suppresses tumorigenesis in basal-like breast cancer. Cancer Cell 25: 210-225.
21. Mudbhary R, Hoshida Y, Chernyavskaya Y, et al. (2014) UHRF1 overexpression drives DNA hypomethylation and hepatocellular carcinoma. Cancer Cell 25: 196-209.
22. Xie Q, Chen L, Shan X, et al. (2014) Epigenetic silencing of SFRP1 and SFRP5 by Hepatitis B Virus X protein enhances hepatoma cell tumorigenicity through wnt signaling pathway. Int J Cancer 135: 635-646.
23. Thiery JP, Acloque H, Huang RY, et al. (2009) Epithelial-mesenchymal transitions in development and disease. Cell 139: 871-890.
24. Zeisberg M and Neilson EG. Biomarkers for epithelial-mesenchymal transitions. Journal of Clinical Investigation 119: 1429-1437.
25. Dey A, Nishiyama A, Karpova T, et al. (2009) Brd4 marks select genes on mitotic chromatin and directs postmitotic transcription. Molecular Biology of the Cell 20: 4899-4909.
26. Rodriguez RM, Suarez-Alvarez B, Salvanes R, et al. (2014) Role of BRD4 in hematopoietic differentiation of embryonic stem cells. Epigenetics 9: 566-578.
27. Lee TK, Poon RT, Yuen AP, et al. (2006) Twist overexpression correlates with hepatocellular carcinoma metastasis through induction of epithelial-mesenchymal transition. Clinical Cancer Research 12: 5369-5376.